Source: Naunyn-Schmiedeberg's Archives of Pharmacology. Unidade: FMRP
Subjects: NEUTRÓFILOS, ÓXIDO NÍTRICO, FARMACOTERAPIA
ABNT
DAL SECCO, Daniela et al. Reduction of ICAM-1 expression by carbon monoxide via soluble guanylate cyclase activation accounts for modulation of neutrophil migration. Naunyn-Schmiedeberg's Archives of Pharmacology, v. 381, n. 6, p. 483-493, 2010Tradução . . Disponível em: https://doi.org/10.1007/s00210-010-0500-2. Acesso em: 15 nov. 2024.APA
Dal Secco, D., Freitas, A., Abreu, M. A., Garlet, T. P., Rossi, M. A., Ferreira, S. H., et al. (2010). Reduction of ICAM-1 expression by carbon monoxide via soluble guanylate cyclase activation accounts for modulation of neutrophil migration. Naunyn-Schmiedeberg's Archives of Pharmacology, 381( 6), 483-493. doi:10.1007/s00210-010-0500-2NLM
Dal Secco D, Freitas A, Abreu MA, Garlet TP, Rossi MA, Ferreira SH, Silva JS da, Alves-Filho JC, Cunha FQ. Reduction of ICAM-1 expression by carbon monoxide via soluble guanylate cyclase activation accounts for modulation of neutrophil migration [Internet]. Naunyn-Schmiedeberg's Archives of Pharmacology. 2010 ; 381( 6): 483-493.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1007/s00210-010-0500-2Vancouver
Dal Secco D, Freitas A, Abreu MA, Garlet TP, Rossi MA, Ferreira SH, Silva JS da, Alves-Filho JC, Cunha FQ. Reduction of ICAM-1 expression by carbon monoxide via soluble guanylate cyclase activation accounts for modulation of neutrophil migration [Internet]. Naunyn-Schmiedeberg's Archives of Pharmacology. 2010 ; 381( 6): 483-493.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1007/s00210-010-0500-2